Assignee
ANADYS PHARMACEUTICALS INC
US·39 granted patents·16 pending applications·534 citations·filing 1997–2014
Top patents by PatentIndex Score
55 records- 0197US8034802B2Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virusANADYS PHARMACEUTICALS INC·Filed 2009·Granted Oct 11, 2011·43 cites·33 claims
- 0297US7576068B2Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virusANADYS PHARMACEUTICALS INC·Filed 2004·Granted Aug 18, 2009·91 cites·20 claims
- 0397US6924271B23-β-D-ribofuranosylthiazolo[4-5-d]pyridimine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2002·Granted Aug 2, 2005·123 cites·10 claims
- 0492US7560544B23,5-Disubsitituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereofANADYS PHARMACEUTICALS INC·Filed 2005·Granted Jul 14, 2009·16 cites·12 claims
- 0591US7834009B24-hydroxy-5,6-dihydro-1H-pyridin-2-one compoundsANADYS PHARMACEUTICALS INC·Filed 2007·Granted Nov 16, 2010·11 cites·19 claims
- 0690US7939524B25,6-dihydro-1H-pyridin-2-one compoundsANADYS PHARMACEUTICALS INC·Filed 2008·Granted May 10, 2011·16 cites·27 claims
- 0789US7709448B2Prodrugs of 5-amino-3-(3′-deoxy-β-D-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dioneANADYS PHARMACEUTICALS INC·Filed 2007·Granted May 4, 2010·13 cites·8 claims
- 0888US6569628B2Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acidsANADYS PHARMACEUTICALS INC·Filed 2001·Granted May 27, 2003·16 cites·9 claims
- 0987US7582626B25,6-dihydro-1H-pyridin-2-one compoundsANADYS PHARMACEUTICALS INC·Filed 2007·Granted Sep 1, 2009·13 cites·20 claims
- 1085US7745415B23-β-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2008·Granted Jun 29, 2010·6 cites·12 claims
- 1185US7582754B2Pyrro[1,2-b]pyridazinone compoundsANADYS PHARMACEUTICALS INC·Filed 2008·Granted Sep 1, 2009·6 cites·4 claims
- 1283US7462611B2Pyrro[1,2-b]pyridazinone compoundsANADYS PHARMACEUTICALS INC·Filed 2007·Granted Dec 9, 2008·5 cites·23 claims
- 1383US7425552B2Pyridazinone compoundsANADYS PHARMACEUTICALS INC·Filed 2005·Granted Sep 16, 2008·7 cites·14 claims
- 1483US7223759B2Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compoundsANADYS PHARMACEUTICALS INC·Filed 2004·Granted May 29, 2007·21 cites·11 claims
- 1580US7928085B2P-toluene sulfonic acid salt of 5-amino-3-(2′-O-acetyl-3′-deoxy-β-D-ribofuranosyl)-3H-thiazole[4,5-d]pyrimidine-2-one and methods for preparationANADYS PHARMACEUTICALS INC·Filed 2007·Granted Apr 19, 2011·4 cites·10 claims
- 1680US6331392B1Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acidsANADYS PHARMACEUTICALS INC·Filed 1998·Granted Dec 18, 2001·29 cites·9 claims
- 1779US7943759B23-β-D-ribofuranosylthiazolo[4-5-d]pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2010·Granted May 17, 2011·3 cites·6 claims
- 1879US6503721B2Screen for compounds with affinity for nucleic acidsANADYS PHARMACEUTICALS INC·Filed 2001·Granted Jan 7, 2003·12 cites·9 claims
- 1977US6531289B1Regulated gene expression in yeast and method of useANADYS PHARMACEUTICALS INC·Filed 2000·Granted Mar 11, 2003·6 cites·10 claims
- 2077US6329378B1Hydrazone, hydrazine and thiosemicarbazone derivatives as antifungal agentsANADYS PHARMACEUTICALS INC·Filed 2000·Granted Dec 11, 2001·13 cites·11 claims
- 2176US7321033B23-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2004·Granted Jan 22, 2008·7 cites·11 claims
- 2275US7528115B2Carbonate and carbamate prodrugs of thiazolo[4,5-d]pyrimidinesANADYS PHARMACEUTICALS INC·Filed 2007·Granted May 5, 2009·2 cites·15 claims
- 2371US9227992B2Method of preparing deoxyribofuranose compoundsANADYS PHARMACEUTICALS INC·Filed 2014·Granted Jan 5, 2016·0 cites·1 claims
- 2469US2011229438A1Method of inhibiting hepatitus c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compoundsANADYS PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2568US7842838B2Pyrro[1,2-b]pyridazinone intermediatesANADYS PHARMACEUTICALS INC·Filed 2009·Granted Nov 30, 2010·0 cites·4 claims
- 2668US6930095B2Hepatitis C virus constructs characterized by high efficiency replicationANADYS PHARMACEUTICALS INC·Filed 2001·Granted Aug 16, 2005·12 cites·8 claims
- 2768US6228882B1Pyronin antibacterials, process and novel intermediates theretoANADYS PHARMACEUTICALS INC·Filed 1999·Granted May 8, 2001·8 cites·10 claims
- 2867US6451582B1Staphylococcus strains comprising an inducible gene encoding an RNA polymerase specificity factorANADYS PHARMACEUTICALS INC·Filed 2000·Granted Sep 17, 2002·2 cites·14 claims
- 2965US9156832B25,6-dihydro-1H-pyridin-2-one compoundsANADYS PHARMACEUTICALS INC·Filed 2014·Granted Oct 13, 2015·0 cites·18 claims
- 3064US8765741B25,6-dihydro-1H-pyridin-2-one compoundsANADYS PHARMACEUTICALS INC·Filed 2013·Granted Jul 1, 2014·0 cites·22 claims
- 3161US2005182001A13-beta-D-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 3259US2014066396A1Method of inhibiting hepatitus c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compoundsANADYS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3358US6191288B1Pyronin antibacterials, process and novel intermediates theretoANADYS PHARMACEUTICALS INC·Filed 1999·Granted Feb 20, 2001·14 cites·13 claims
- 3458US2008090844A13-beta-D-Ribofuranosylthiazalo [4-5-d] pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 3557US2007197533A1Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compoundsANADYS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 3655US2013137143A1Semi-continuous and continuous enzymatic hydrolysis processANADYS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3755US2011166092A1Dosing methods for treating diseaseANADYS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3854US9161946B2Dosing methods for treating diseaseANADYS PHARMACEUTICALS INC·Filed 2013·Granted Oct 20, 2015·0 cites·4 claims
- 3952US6355469B1Nucleic acid encoding M. tuberculosis algu proteinANADYS PHARMACEUTICALS INC·Filed 1998·Granted Mar 12, 2002·9 cites·4 claims
- 4051US2008292588A11-methyl-benzo[1,2,4]thiadiazine 1-oxide derivativesANADYS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 4148US2008188466A1Pyridazinone compoundsANADYS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 4247US7781581B2Process for the preparation of 5-amino-3H-thiazolo[4,5-d]pyrimidin-2-oneANADYS PHARMACEUTICALS INC·Filed 2006·Granted Aug 24, 2010·0 cites·16 claims
- 4347US6358708B1Candida albicans SRB-7ANADYS PHARMACEUTICALS INC·Filed 2000·Granted Mar 19, 2002·0 cites·6 claims
- 4447US2010286081A15-amino-3-(2',3'-di-o-acetyl-beta-d-ribofuranosyl)-3h-thiazolo[4,5-d] pyrimidin-2-oce salts and crystalline formsANADYS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 4546US2008090814A1Pyridazinone compoundsANADYS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 4644US6610508B1Translation driver system and methods for use thereofANADYS PHARMACEUTICALS INC·Filed 1999·Granted Aug 26, 2003·15 cites·107 claims
- 4744US2005075375A1Heterocyclic compounds for treating hepatitis C virusANADYS PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 4843US2002055123A1Screening method for identifying ligands for target proteinsANADYS PHARMACEUTICALS INC·Filed 2001·Application pending·0 cites
- 4941US2005260221A1Hepatitis C virus constructs characterized by high efficiency replicationANADYS PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 5037US2003027243A1Antifungal compounds and methods of useANADYS PHARMACEUTICALS INC·Filed 2001·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →